Menu
Recruiting NCT07075159

Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing

No phase Interventional Wound Healing Mohs Micrographic Surgery Oculofacial Reconstruction

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Hydrocolloid Wound Dressing.
Who it may be relevant to
Registry conditions: Wound Healing, Mohs Micrographic Surgery, Oculofacial Reconstruction. Basic parameters: 18 years — 100 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.

Interventions

  • Device Hydrocolloid Wound Dressing
    one time hydrocolloid dressing application

Primary outcome measures

  • Number of participants with wound dehiscence [Time frame: 3 months]
Secondary outcome measures (1)
  • Patient and Observer Scar Assessment Scale [Time frame: 3 months]

Eligibility criteria

Inclusion criteria

  • Patients >18 years of age
  • follow-up at specified intervals (1 week/6 week/3 months) in an office setting
  • can give informed consent
  • no patients will be excluded on the basis of gender, ethnicity, or religious background

Exclusion criteria

  • Patients <18 years of age or >100
  • allergy to pectin, gelatin, and sodium carboxymethylcellulose
  • adults with impaired consent capacity
  • incarcerated individuals.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • University of Kentucky — Lexington

Identifiers

NCT: NCT07075159 · 99942

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗